Comment
doi: 10.1016/S0140-6736(14)62125-5.
Epub 2014 Nov 16.
Dual antiplatelet therapy and non-cardiovascular mortality
Affiliations
- PMID: 25467568
- DOI: 10.1016/S0140-6736(14)62125-5
Item in Clipboard
Comment
Dual antiplatelet therapy and non-cardiovascular mortality
Lancet.
.
No abstract available
Comment on
-
Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.Lancet. 2015 Feb 28;385(9970):792-8. doi: 10.1016/S0140-6736(14)62052-3. Epub 2014 Nov 16. Lancet. 2015. PMID: 25467565 Free PMC article. Review.
Similar articles
-
Dual antiplatelet therapy duration and mortality.Lancet. 2015 May 30;385(9983):2149. doi: 10.1016/S0140-6736(15)61018-2. Lancet. 2015. PMID: 26068263 No abstract available.
-
Dual antiplatelet therapy duration and mortality - Authors' reply.Lancet. 2015 May 30;385(9983):2149-50. doi: 10.1016/S0140-6736(15)61019-4. Lancet. 2015. PMID: 26068262 No abstract available.
-
Antiplatelet therapy: risks and benefits of extended DAPT after stenting.Nat Rev Cardiol. 2015 Jan;12(1):1. doi: 10.1038/nrcardio.2014.192. Epub 2014 Dec 2. Nat Rev Cardiol. 2015. PMID: 25445134 No abstract available.
-
Platelet function testing as a biomarker for efficacy of antiplatelet drugs.Biomark Med. 2016 Aug;10(8):903-18. doi: 10.2217/bmm-2016-0070. Epub 2016 Jul 14. Biomark Med. 2016. PMID: 27414976 Review.
-
Antiplatelet treatment in essential hypertension: where do we stand?Curr Hypertens Rep. 2015 Apr;17(4):536. doi: 10.1007/s11906-015-0536-2. Curr Hypertens Rep. 2015. PMID: 25790800 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
